Financials
- Market Capitalization 36.3476 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG012QXTPF0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
—
Relación precio/flujo de caja
—
Dividendos por acción
—
Rendimiento por dividendo, %
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4355 | CRVO CervoMed Inc. - Common Stock | 2.60 USD | -1.52% | -1.89% | +5.26% | -73.06% | 39.31 M USD | ||
| 4377 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.18 USD | -4.39% | -24.57% | -56.92% | -77.07% | 36.91 M USD | ||
| 4405 | CNTX Context Therapeutics Inc. - Common Stock | 0.38 USD | -9.52% | -22.45% | -38.71% | -55.29% | 34.91 M USD | ||
| 4408 | QNCX Quince Therapeutics, Inc. - Common Stock | 33.75 USD | +3.85% | +2.27% | +54.75% | +1970.55% | 34.33 M USD |